OraSure Technologies Crecimiento futuro

Future controles de criterios 0/6

OraSure TechnologiesSe prevé que los ingresos y beneficios de la empresa disminuyan en 36.8% y 123% al año, respectivamente. Se prevé que el BPA sea de decline en 125.9% al año. Se prevé que la rentabilidad de los fondos propios sea de 3% en 3 años.

Información clave

-140.4%

Tasa de crecimiento de los beneficios

-141.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.5%
Tasa de crecimiento de los ingresos	-36.8%
Rentabilidad financiera futura	3.0%
Cobertura de analistas	Good
Última actualización	04 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01

Recent updates

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

Apr 17

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Feb 29

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Dec 20

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Nov 08

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Aug 09

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

May 16

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

May 13

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Feb 17

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Jun 14

OraSure: Not So Sure With Softening Fundamentals, Fairly Priced At $2.54

Jun 10

OraSure Technologies: A Bet On What Used To Be

Mar 05

OraSure Technologies (NASDAQ:OSUR) May Have Issues Allocating Its Capital

Nov 11

The Bottom Fishing Club: OraSure Technologies

Oct 22

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:OSUR - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	185	N/A	N/A	N/A	2
12/31/2025	167	-18	N/A	N/A	5
12/31/2024	191	-9	22	29	6
12/31/2023	405	54	131	142	N/A
9/30/2023	453	49	76	82	N/A
6/30/2023	480	43	50	62	N/A
3/31/2023	475	29	-25	-5	N/A
12/31/2022	387	-17	-111	-47	N/A
9/30/2022	328	-43	-129	-42	N/A
6/30/2022	265	-64	-162	-77	N/A
3/31/2022	243	-47	-152	-67	N/A
12/31/2021	234	-23	-83	-35	N/A
9/30/2021	233	-11	-62	-19	N/A
6/30/2021	227	5	-39	5	N/A
3/31/2021	199	-4	-36	-1	N/A
12/31/2020	172	-15	-23	6	N/A
9/30/2020	158	-14	-14	1	N/A
6/30/2020	146	-2	-9	3	N/A
3/31/2020	156	13	0	12	N/A
12/31/2019	155	17	0	10	N/A
9/30/2019	150	25	17	25	N/A
6/30/2019	159	20	22	30	N/A
3/31/2019	161	19	25	32	N/A
12/31/2018	182	20	33	39	N/A
9/30/2018	177	17	16	23	N/A
6/30/2018	174	15	13	20	N/A
3/31/2018	174	16	18	23	N/A
12/31/2017	166	31	24	28	N/A
9/30/2017	145	31	N/A	30	N/A
6/30/2017	135	31	N/A	30	N/A
3/31/2017	126	30	N/A	32	N/A
12/31/2016	123	20	N/A	25	N/A
9/30/2016	125	17	N/A	26	N/A
6/30/2016	123	12	N/A	36	N/A
3/31/2016	122	11	N/A	27	N/A
12/31/2015	120	8	N/A	16	N/A
9/30/2015	116	1	N/A	14	N/A
6/30/2015	114	1	N/A	15	N/A
3/31/2015	110	1	N/A	9	N/A
12/31/2014	106	-5	N/A	8	N/A
9/30/2014	107	4	N/A	20	N/A
6/30/2014	103	1	N/A	7	N/A
3/31/2014	101	-7	N/A	8	N/A
12/31/2013	99	-11	N/A	8	N/A
9/30/2013	92	-23	N/A	-5	N/A
6/30/2013	90	-24	N/A	-12	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: OSURSe prevé que los beneficios de la empresa disminuyan en los próximos 3 años (-123% al año).

Beneficios vs. Mercado: OSURSe prevé que los beneficios de la empresa disminuyan en los próximos 3 años (-123% al año).

Beneficios de alto crecimiento: OSURSe prevé que los beneficios de la empresa disminuyan en los próximos 3 años.

Ingresos vs. Mercado: OSURSe prevé que los ingresos de la empresa disminuyan en los próximos 3 años (-41.4% al año).

Ingresos de alto crecimiento: OSURSe prevé que los ingresos de la empresa disminuyan en los próximos 3 años (-40.3% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: OSURSe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (1%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

OraSure Technologies Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

OraSure Technologies, Inc. Provides Financial Guidance for the Fourth Quarter 2023

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2023

Price target decreased by 7.2% to US$6.45

Price target increased by 13% to US$6.95

Orasure Technologies, Inc. Provides Earnings Guidance for the Second Quarter 2023

Recent updates

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

New minor risk - Shareholder dilution

OraSure Technologies, Inc., Annual General Meeting, May 14, 2024

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

New minor risk - Earnings quality

OraSure Technologies, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Full year 2023 earnings: EPS exceeds analyst expectations

OraSure Technologies, Inc. to Report Fiscal Year 2023 Results on Feb 27, 2024

Chief Product Officer notifies of intention to sell stock

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Investor sentiment improves as stock rises 18%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Financial Guidance for the Fourth Quarter 2023

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

OraSure Technologies, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investor sentiment improves as stock rises 41%

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2023

OraSure Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023

OraSure Technologies, Inc. Announces Election of Robert W. McMahon to its Board of Directors, Effective July 31, 2023

Price target decreased by 7.2% to US$6.45

OraSure Technologies, Inc. Announces Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

Investor sentiment improves as stock rises 17%

Chief Financial Officer recently bought US$493k worth of stock

Investor sentiment deteriorates as stock falls 22%

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Price target increased by 13% to US$6.95

Orasure Technologies, Inc. Provides Earnings Guidance for the Second Quarter 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. to Report Q1, 2023 Results on May 10, 2023

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Price target increased by 8.0% to US$5.88

Full year 2022 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the First Quarter of 2023

OraSure Technologies, Inc. to Report Q4, 2022 Results on Feb 14, 2023

We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

Consensus estimates of losses per share improve by 69%

High number of new directors

OraSure Technologies, Inc. Announces Executive Changes

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Reports Goodwill and Long-Lived Assets Impairment Charges for the Third Quarter Ended September 30, 2022

Orasure Technologies Receives General Clearance for Its ORAcollect--Dx Device for over the Counter Use from the U.S. Food and Drug Administration

OraSure Technologies, Inc. Announces InteliSwab Covid-19 Rapid Test Now Available in Amazon’s Online Store

OraSure Technologies, Inc. to Report Q3, 2022 Results on Nov 08, 2022

OraSure wins $8.6M government contract for next-gen Ebola test

OraSure: Revenue Mix Continues To Present Risk

Independent Director recently bought US$200k worth of stock

Biden administration ending free at-home COVID tests due to lack of funding

Independent Chairman of the Board recently bought US$54k worth of stock

Consensus revenue estimates increase by 11%

OraSure Technologies, Inc. Announces CFO Changes

Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Invest In Growth?

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2022

OraSure Technologies, Inc. to Report Q2, 2022 Results on Aug 09, 2022

OraSure Technologies, Inc. Announces Executive Changes

OraSure Technologies LaunchesNewProduct for Microbiome Researchers to Study DNA and RNA

OraSure Technologies, Inc.(NasdaqGS:OSUR) dropped from Russell 2000 Value-Defensive Index

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

OraSure Technologies, Inc. Announces Resignation of Agnieszka M. Gallagher as Executive Vice President, General Counsel and Chief Compliance Officer, Effective June 25, 2022

OraSure: Not So Sure With Softening Fundamentals, Fairly Priced At $2.54

OraSure Technologies, Inc. Appoints Carrie Eglinton Manner as President, Effective June 4, 2022

OraSure Technologies, Inc. Announces That Its InteliSwab® Covid-19 Rapid Tests Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to US$10.90